• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Target of Myb protein 1 (TOM1)

ACP21186

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21186 Target NameTOM1
Target SynonymsTOM1; Target of Myb protein 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-492
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO60784
Background Information
  • Uniprot Id

    O60784

  • Target Species

    Human

  • Target Name

    TOM1

  • Target Full Name

    Target of Myb1 membrane trafficking protein

  • Target Function

    May be involved in intracellular trafficking. Probable association with membranes.

  • Target Subcellular Location

    Cytoplasm. Membrane; Peripheral membrane protein.

  • Target Protein Families

    TOM1 family

  • Target Tissue Specificity

    Widely expressed. Highly expressed in skeletal muscle, heart, placenta and liver.

  • Target Synonyms

    TOM1; Target of Myb protein 1

  • Target Background

    This gene was identified as a target of the v-myb oncogene. The encoded protein shares its N-terminal domain in common with proteins associated with vesicular trafficking at the endosome. It is recruited to the endosomes by its interaction with endofin. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human Target of Myb protein 1 (TOM1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification